靶向去泛素化酶抑制病理性心肌肥大的新作用 - Suppr

Suppr

超能文献

Emerging Role of Targeting Deubiquitinating Enzymes to Inhibit Pathological Cardiac Hypertrophy.

作者信息

Liu Ren Ping, McMullen Julie R

机构信息

Heart Research Institute Newtown NSW Australia.

出版信息

J Am Heart Assoc. 2025 Mar 18;14(6):e039732. doi: 10.1161/JAHA.124.039732. Epub 2025 Mar 5.

DOI:10.1161/JAHA.124.039732

PMID:40040615

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12132781/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3326/12132781/345d16e672fa/JAH3-14-e039732-g001.jpg

相似文献

Emerging Role of Targeting Deubiquitinating Enzymes to Inhibit Pathological Cardiac Hypertrophy.

J Am Heart Assoc. 2025 Mar 18;14(6):e039732. doi: 10.1161/JAHA.124.039732. Epub 2025 Mar 5.

Deubiquitinase Ubiquitin-Specific Protease 29 Ameliorates Pathological Cardiac Hypertrophy through Inhibiting Transforming Growth Factor β-Activated Kinase 1.

J Am Heart Assoc. 2025 Mar 18;14(6):e034962. doi: 10.1161/JAHA.124.034962. Epub 2025 Mar 5.

The emerging role of USP29 in cancer and other diseases.

Cell Biochem Funct. 2024 Jan;42(1):e3928. doi: 10.1002/cbf.3928.

Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Pathological Cardiac Hypertrophy.

Hypertension. 2016 Jun;67(6):1237-48. doi: 10.1161/HYPERTENSIONAHA.116.07392. Epub 2016 Apr 4.

Ubiquitin-specific protease 29 attenuates hepatic ischemia-reperfusion injury by mediating TGF-β-activated kinase 1 deubiquitination.

Front Immunol. 2023 May 26;14:1167667. doi: 10.3389/fimmu.2023.1167667. eCollection 2023.

Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway.

J Cell Mol Med. 2020 Sep;24(18):10946-10957. doi: 10.1111/jcmm.15724. Epub 2020 Aug 14.

Ubiquitin Specific Protease 29 Functions as an Oncogene Promoting Tumorigenesis in Colorectal Carcinoma.

Cancers (Basel). 2021 May 31;13(11):2706. doi: 10.3390/cancers13112706.

Loss of USP22 alleviates cardiac hypertrophy induced by pressure overload through HiF1-α-TAK1 signaling pathway.

Biochim Biophys Acta Mol Basis Dis. 2023 Dec;1869(8):166813. doi: 10.1016/j.bbadis.2023.166813. Epub 2023 Jul 23.

Self-stabilizing regulation of deubiquitinating enzymes in an enzymatic activity-dependent manner.

Int J Biol Macromol. 2021 Jun 30;181:1081-1091. doi: 10.1016/j.ijbiomac.2021.04.073. Epub 2021 Apr 14.

The role of deubiquitinases in cardiac disease.

Expert Rev Mol Med. 2024 Mar 25;26:e3. doi: 10.1017/erm.2024.2.

本文引用的文献

Deubiquitinase Ubiquitin-Specific Protease 29 Ameliorates Pathological Cardiac Hypertrophy through Inhibiting Transforming Growth Factor β-Activated Kinase 1.

J Am Heart Assoc. 2025 Mar 18;14(6):e034962. doi: 10.1161/JAHA.124.034962. Epub 2025 Mar 5.

Deubiquitinase USP25 Alleviates Obesity-Induced Cardiac Remodeling and Dysfunction by Downregulating TAK1 and Reducing TAK1-Mediated Inflammation.

JACC Basic Transl Sci. 2024 Aug 7;9(11):1287-1304. doi: 10.1016/j.jacbts.2024.06.001. eCollection 2024 Nov.

UBR1 Promotes Sex-Dependent ACE2 Ubiquitination in Hypertension.

Hypertension. 2025 Jan;82(1):84-95. doi: 10.1161/HYPERTENSIONAHA.124.23196. Epub 2024 Nov 27.

TRIM35 Monoubiquitinates H2B in Cardiac Cells, Implications for Heart Failure.

Circ Res. 2024 Jul 5;135(2):301-313. doi: 10.1161/CIRCRESAHA.123.324202. Epub 2024 Jun 11.

The role of deubiquitinases in cardiac disease.

Expert Rev Mol Med. 2024 Mar 25;26:e3. doi: 10.1017/erm.2024.2.

A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology.

J Mol Med (Berl). 2024 Jan;102(1):95-111. doi: 10.1007/s00109-023-02397-2. Epub 2023 Nov 21.

Deubiquitylating Enzymes in Cancer and Immunity.

Adv Sci (Weinh). 2023 Dec;10(36):e2303807. doi: 10.1002/advs.202303807. Epub 2023 Oct 27.

RNF13 protects against pathological cardiac hypertrophy through p62-NRF2 pathway.

Free Radic Biol Med. 2023 Nov 20;209(Pt 2):252-264. doi: 10.1016/j.freeradbiomed.2023.10.395. Epub 2023 Oct 16.

Ubiquitin-specific protease 29 attenuates hepatic ischemia-reperfusion injury by mediating TGF-β-activated kinase 1 deubiquitination.

Front Immunol. 2023 May 26;14:1167667. doi: 10.3389/fimmu.2023.1167667. eCollection 2023.

Nedd4-2 up-regulation is associated with ACE2 ubiquitination in hypertension.

Cardiovasc Res. 2023 Sep 5;119(11):2130-2141. doi: 10.1093/cvr/cvad070.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验